Comparative Trial in Compression Therapy in Leg Lymphedema
Primary Purpose
Leg Lymphedema
Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Regular Compression therapy (Trico bandages)
New Compression therapy (C2L bandages)
Sponsored by
About this trial
This is an interventional treatment trial for Leg Lymphedema focused on measuring leg lymphedema, volume measurement, compression therapy, interface pressure, static stiffness index (SSI), volume change
Eligibility Criteria
Inclusion Criteria:
- Gender: male or female
- More than 18 years of age
- Patients with distal lymphedema of the leg requiring multilayer lymphedema bandaging of the leg
- The patient is able to understand the study and is willing to give written informed consent to the study
Exclusion Criteria:
- Allergy against one of the used materials
- Proximal lymphedema (involvement of thigh, genitalia)
- Severe systemic diseases causing peripheral oedema
- Acute superficial or deep vein thrombosis
- Arterial occlusive disease (stadium II, III or IV) or arm/leg blood pressure index (ALPI)<0,8
- Local infection in the therapy area
- Auto-immunological disorders or vasculitis
- Use of systemic corticosteroids
Sites / Locations
- Nij Smellinghe hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
1
2
Arm Description
Regular compression therapy with non elastic trico bandaging
New two layer compression bandage coban 2
Outcomes
Primary Outcome Measures
volume decrease in relation to interface pressure after application of two types of bandages.
Secondary Outcome Measures
Pressure drop after 2 hours and 24 hours of bandaging
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00665379
Brief Title
Comparative Trial in Compression Therapy in Leg Lymphedema
Official Title
Prospective, Randomized Controlled Trial Comparing the Effect of 3M Coban 2 Layer Compression System Versus Trico Bandages in the Treatment of Leg Lymphedema.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2012
Overall Recruitment Status
Completed
Study Start Date
April 2008 (undefined)
Primary Completion Date
April 2009 (Actual)
Study Completion Date
May 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nij Smellinghe Hosptial
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this trial is to study the effect of the 3M Coban 2 Layer Compression System (hereafter C2L) in the treatment of leg lymphedema compared to the traditional treatment with Trico bandages.
Detailed Description
The goal of this prospective, randomized, controlled trial with CE marked product is to study the effectiveness (volume reduction) of 24-hour compression therapy for lymphedema, comparing C2L and Trico bandaging. Therefore 30 patients with leg lymphedema are included.
Application of marketed compression bandages (C2L or Trico bandages) used for treatment by trained specialists with assessment of the subbandage pressure and volume reduction.
Measurements are carried out at:
Volumetry:
Measurements after 0h, 2h and 24 h by using classic water displacement apparatus.
Pressure:
Measurements after 0h, 2h (pre and post bandage change) and 24 h;
supine and standing to calculate the SSI;
supine with and without dorsal flexion.
for the pressure measurement a Kikuhime (large pads) dice is used. At each new bandaging to document the SSI and the effect of dorsiflexion in the supine position
The subbandage pressure is measured on the medial aspect of the lower leg at the transition of the gastrocnemius muscle into the Achilles' tendon (B1) (Partsch H. et al. Dermatol Surg 2006; 32: 224-233).
Fix the sensor (sensor and tube sheathed with Cellona Soft Padding)
Statistical analysis; Analysis of variance (ANOVA) comparing volume, supine subbandage pressure with and without dorsiflexion, and SSI for the used bandages
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Leg Lymphedema
Keywords
leg lymphedema, volume measurement, compression therapy, interface pressure, static stiffness index (SSI), volume change
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Active Comparator
Arm Description
Regular compression therapy with non elastic trico bandaging
Arm Title
2
Arm Type
Active Comparator
Arm Description
New two layer compression bandage coban 2
Intervention Type
Other
Intervention Name(s)
Regular Compression therapy (Trico bandages)
Other Intervention Name(s)
trico bandages
Intervention Description
Application of marketed Trico compression bandages used for treatment by trained specialists with assessment of the subbandage pressure and volume reduction. The bandages are applicated in patients with leg lymphedema at t=0 hour, t=2 hours. Comparison is made at t=2 hours, t= 24 hours
Intervention Type
Other
Intervention Name(s)
New Compression therapy (C2L bandages)
Other Intervention Name(s)
coban 2
Intervention Description
Application of marketed compression bandages C2L used for treatment by trained specialists with assessment of the subbandage pressure and volume reduction. he bandages are applicated in patients with leg lymphedema at t=0 hour, t=2 hours. Comparison is made at t=2 hours, t= 24 hours
Primary Outcome Measure Information:
Title
volume decrease in relation to interface pressure after application of two types of bandages.
Time Frame
enrollment of 30 patients
Secondary Outcome Measure Information:
Title
Pressure drop after 2 hours and 24 hours of bandaging
Time Frame
after application, at 2 hours and 24 hours after application of bandage
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Gender: male or female
More than 18 years of age
Patients with distal lymphedema of the leg requiring multilayer lymphedema bandaging of the leg
The patient is able to understand the study and is willing to give written informed consent to the study
Exclusion Criteria:
Allergy against one of the used materials
Proximal lymphedema (involvement of thigh, genitalia)
Severe systemic diseases causing peripheral oedema
Acute superficial or deep vein thrombosis
Arterial occlusive disease (stadium II, III or IV) or arm/leg blood pressure index (ALPI)<0,8
Local infection in the therapy area
Auto-immunological disorders or vasculitis
Use of systemic corticosteroids
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
RJ Damstra, MD
Organizational Affiliation
Nij Smellinghe Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
H Partsch, PhD
Organizational Affiliation
Private practice, wien
Official's Role
Study Director
Facility Information:
Facility Name
Nij Smellinghe hospital
City
Drachten
State/Province
Friesland
ZIP/Postal Code
9202NN
Country
Netherlands
12. IPD Sharing Statement
Learn more about this trial
Comparative Trial in Compression Therapy in Leg Lymphedema
We'll reach out to this number within 24 hrs